BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33890690)

  • 21. Founder Mutations for Early Onset Melanoma as Revealed by Whole Exome Sequencing Suggests That This is Not Associated with the Increasing Incidence of Melanoma in Poland.
    Dębniak T; Scott RJ; Lea RA; Górski B; Masojć B; Cybulski C; Kram A; Maleszka R; Gromowski T; Paszkowska-Szczur K; Kashyap A; Lener MR; Malińska K; Rogoża E; Murawa D; Rudnicka H; Deptuła J; Lubiński J
    Cancer Res Treat; 2019 Jan; 51(1):337-344. PubMed ID: 29764119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular and genetic diversity in the metastatic process of melanoma.
    Harbst K; Lauss M; Cirenajwis H; Winter C; Howlin J; Törngren T; Kvist A; Nodin B; Olsson E; Häkkinen J; Jirström K; Staaf J; Lundgren L; Olsson H; Ingvar C; Gruvberger-Saal SK; Saal LH; Jönsson G
    J Pathol; 2014 May; 233(1):39-50. PubMed ID: 24399611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole exome sequencing in recurrent early pregnancy loss.
    Qiao Y; Wen J; Tang F; Martell S; Shomer N; Leung PC; Stephenson MD; Rajcan-Separovic E
    Mol Hum Reprod; 2016 May; 22(5):364-72. PubMed ID: 26826164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of whole-exome sequencing of matched fresh and formalin fixed paraffin embedded melanoma tumours: implications for clinical decision making.
    De Paoli-Iseppi R; Johansson PA; Menzies AM; Dias KR; Pupo GM; Kakavand H; Wilmott JS; Mann GJ; Hayward NK; Dinger ME; Long GV; Scolyer RA
    Pathology; 2016 Apr; 48(3):261-6. PubMed ID: 27020503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach.
    Manca A; Paliogiannis P; Colombino M; Casula M; Lissia A; Botti G; Caracò C; Ascierto PA; Sini MC; Palomba G; Pisano M; ; ; Doneddu V; Cossu A; Palmieri G;
    J Transl Med; 2019 Aug; 17(1):289. PubMed ID: 31455347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BRAF Mutation Analysis in Primary Acral Melanoma of 41 Cases from South of Iran.
    Sari Aslani F; Safaee A; Akbarzadeh Jahromi M; Karami L
    Iran J Pathol; 2021; 16(4):370-375. PubMed ID: 34567185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic Heterogeneity and Branched Evolution of Early Stage Primary Acral Melanoma Shown by Multiregional Microdissection Sequencing.
    Zhang X; Peng Y; Li C; Li Q; Yu Z; Pang Y; Wu AR; Huang Y; Li H
    J Invest Dermatol; 2019 Jul; 139(7):1526-1534. PubMed ID: 30710577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
    Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
    JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Characteristics of Conjunctival Melanoma Using Whole-Exome Sequencing.
    Swaminathan SS; Field MG; Sant D; Wang G; Galor A; Dubovy SR; Harbour JW; Karp CL
    JAMA Ophthalmol; 2017 Dec; 135(12):1434-1437. PubMed ID: 29121185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Whole-exome sequencing reveals critical genes underlying metastasis in oesophageal squamous cell carcinoma.
    Dai W; Ko JMY; Choi SSA; Yu Z; Ning L; Zheng H; Gopalan V; Chan KT; Lee NP; Chan KW; Law SY; Lam AK; Lung ML
    J Pathol; 2017 Aug; 242(4):500-510. PubMed ID: 28608921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Palbociclib in advanced acral melanoma with genetic aberrations in the cyclin-dependent kinase 4 pathway.
    Mao L; Dai J; Cao Y; Bai X; Sheng X; Chi Z; Cui C; Kong Y; Zhang Y; Wu L; Wang X; Tang B; Lian B; Yan X; Li S; Zhou L; Wei X; Li C; Qi Z; Si L; Guo J
    Eur J Cancer; 2021 May; 148():297-306. PubMed ID: 33770575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel enriched pathways in superficial malignant peripheral nerve sheath tumours and spindle/desmoplastic melanomas.
    Jour G; Andeen NK; Al-Rohil R; Aung PP; Mehrotra M; Duose D; Hoch B; Argenyi Z; Luthra R; Wistuba II; Prieto VG
    J Pathol; 2018 Jan; 244(1):97-106. PubMed ID: 28991373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BRAF, KIT, and NRAS Mutations of Acral Melanoma in White Patients.
    Dika E; Veronesi G; Altimari A; Riefolo M; Ravaioli GM; Piraccini BM; Lambertini M; Campione E; Gruppioni E; Fiorentino M; Melotti B; Ferracin M; Patrizi A
    Am J Clin Pathol; 2020 Apr; 153(5):664-671. PubMed ID: 32017841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whole-exome sequencing of familial cases of multiple morphological abnormalities of the sperm flagella (MMAF) reveals new DNAH1 mutations.
    Amiri-Yekta A; Coutton C; Kherraf ZE; Karaouzène T; Le Tanno P; Sanati MH; Sabbaghian M; Almadani N; Sadighi Gilani MA; Hosseini SH; Bahrami S; Daneshipour A; Bini M; Arnoult C; Colombo R; Gourabi H; Ray PF
    Hum Reprod; 2016 Dec; 31(12):2872-2880. PubMed ID: 27798045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of molecular testing in advanced melanoma on outcomes in a tertiary cancer center and as reported in a publicly available database.
    Dimitrova M; Kim MJ; Osman I; Jour G
    Cancer Rep (Hoboken); 2021 Aug; 4(4):e1380. PubMed ID: 34109763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Profile of Genetic Mutations in Papillary Thyroid Cancer Detected by Whole Exome Sequencing.
    Fang Y; Ma X; Zeng J; Jin Y; Hu Y; Wang J; Liu R; Cao C
    Cell Physiol Biochem; 2018; 50(1):169-178. PubMed ID: 30278442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma.
    Huang A; Zhao X; Yang XR; Li FQ; Zhou XL; Wu K; Zhang X; Sun QM; Cao Y; Zhu HM; Wang XD; Yang HM; Wang J; Tang ZY; Hou Y; Fan J; Zhou J
    J Hepatol; 2017 Aug; 67(2):293-301. PubMed ID: 28323123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of genomic evolution in advanced melanoma.
    Birkeland E; Zhang S; Poduval D; Geisler J; Nakken S; Vodak D; Meza-Zepeda LA; Hovig E; Myklebost O; Knappskog S; Lønning PE
    Nat Commun; 2018 Jul; 9(1):2665. PubMed ID: 29991680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acral melanoma foot lesions. Part 2: clinical presentation, diagnosis, and management.
    Desai A; Ugorji R; Khachemoune A
    Clin Exp Dermatol; 2018 Mar; 43(2):117-123. PubMed ID: 29235153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole-exome sequencing reveals differences between nail apparatus melanoma and acral melanoma.
    Lee M; Yoon J; Chung YJ; Lee SY; Choi JY; Shin OR; Park HY; Bahk WJ; Yu DS; Lee YB
    J Am Acad Dermatol; 2018 Sep; 79(3):559-561.e1. PubMed ID: 29438763
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.